Article
Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals.
Alzheimer's & dementia : the journal of the Alzheimer's Association - 1 Sept 2024
Lorenzini Luigi, Collij Lyduine E, Tesi Niccoló, Vilor-Tejedor Natàlia, Ingala Silvia, Blennow Kaj, Foley Christopher, Frisoni Giovanni B, Haller Sven, Holstege Henne, van der van der Lee Sven, Martinez-Lage Pablo, Marioni Riccardo E, McCartney Daniel L, O' Brien John, Oliveira Tiago Gil, Payoux Pierre, Reinders Marcel, Ritchie Craig, Scheltens Philip, Schwarz Adam J, Sudre Carole H, Waldman Adam D, Wolz Robin, Chatelat Gael, Ewers Michael, Wink Alle Meije, Mutsaerts Henk J M M, Gispert Juan Domingo, Visser Pieter Jelle, Tijms Betty M, Altmann Andre, Barkhof Frederik
Abstract excerpt
INTRODUCTION: Unraveling how Alzheimer's disease (AD) genetic risk is related to neuropathological heterogeneity, and whether this occurs through specific biological pathways, is a key step toward precision medicine. METHODS: We computed pathway-specific genetic risk scores (GRSs) in non-demented individuals and investigated how AD risk variants predict cerebrospinal fluid (CSF) and imaging biomarkers reflecting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
